Balchem Corp
Bear Case (25th pct.)
-66.1% vs price
Base Case (Median)
-56.3% vs price
Bull Case (75th pct.)
-50.8% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $21.75 | -87.8% | High (40%) |
| PE Comparable | $89.99 | -49.6% | Medium (25%) |
| Growth Trajectory DCF | $85.44 | -52.1% | Medium (20%) |
| Graham Number | $66.39 | -62.8% | Medium (30%) |
| EV/EBITDA | $78.04 | -56.3% | Medium (20%) |
| EV/FCF | $105.12 | -41.1% | Medium (20%) |
| Earnings Power Value | $54.45 | -69.5% | Medium (50%) |
Based on 7 out of 8 methods, BCPC appears overvalued at the current price of $178.38. The base case fair value of $78.04 implies 56.3% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.